Topic: Patent Pools

Latest content

AI-powered patent pools open for business despite some market scepticism

Two newly launched licensing platforms say the moment has arrived to deploy the rapidly developing technology, but not everyone is convinced

07 January 2022

Open RAN patent pool raises eyebrows, but operators promise balance

Critics suggest Alium will favour implementers by offering royalty rates that are inadequate for licensors

05 January 2022

Dusseldorf court delivers first FRAND defeat for an SEP joint licensing programme

Vestel fights off injunction requests in cases brought by GE, Dolby, Philips and IP Bridge, members of the of an HEVC platform administered by Access Advance

23 December 2021

Avanci agrees licensing deal with Daimler to round-off a successful 2021

Agreement includes 4G and means the platform now has the big three German car manufacturers under licence – but only for 3G with VW

22 December 2021

Avanci CEO predicts solutions – not litigation – for connected car makers in 2022

Kasim Alfalahi says educating OEMs about telecoms standards and essential patents has taken some time, but they are turning a corner

17 December 2021

IP leaders weigh in on what makes or breaks a patent pool

From the need for clarity to the problems of self-certification, top practitioners give their prescriptions for making the most of the pool model

07 December 2021

New report calls for greater antitrust clarity and relaxed regulation of patent pools in China

Advisor to top court says joint patent licensing platforms are pro-competitive and should be nurtured under China’s anti-monopoly regime

02 December 2021

Chinese law should do more to encourage joint patent licensing, says adviser to country's IP courts

Professor Cui Guobin says that both patent owners and implementers want greater clarity around pools and antitrust law

22 November 2021

Patent suits decline in Dusseldorf and Mannheim, but Munich’s docket is on the rise

Germany is Europe’s biggest and most active litigation forum, but subtle differences in case law and proceedings mean that plaintiffs have important choices to make about where to file their suits

16 November 2021

Key takeaways from Merck’s landmark covid IP licensing deal with the Medicines Patent Pool

The agreement is the first granting non-exclusive and royalty free rights to sub-licensees of a covid therapeutic or vaccine

02 November 2021

Get unlimited access to all IAM content